ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the US, providing a new option for treating Type I allergic reactions, including anaphylaxis ...

Get Instant Summarized Text (Gist) An engineered IgM-based monoclonal antibody delivered via nasal spray provided strong protection to mice against lethal influenza A infection, including H1N1 and ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years. The Food and Drug ...

Corstasis Therapeutics Inc. took inspiration from Narcan when coming up for its own nasal spray. “It got me thinking, ‘What could we potentially repurpose into a nasal spray for cardiology?’” Chief ...

DEAR DR ROACH: I have a cold. I use two brands of nasal spray for congestion, but both say not to use them for more than three days as they may cause “rebound” congestion. Can I alternate them ...

In fact the damage was down to the repeated use of nasal decongestants, which Curtis had first used to overcome the bunged-up sensation brought on by a cold. Soon he was reaching for a spray ...

Please provide your email address to receive an email when new articles are posted on . Nasal spray offers an alternative for patients who are afraid of needles. Participants absorbed epinephrine ...

She showed us around her home in Fleetwood, Lancashire, revealing bottles of nasal spray in every room. One on the mantelpiece, another in her bedside draw, and more in her bathroom, kitchen ...

The US Food and Drug Administration (FDA) has approved dihydroergotamine (DHE) nasal powder (Atzumi, Satsuma Pharmaceuticals Inc) for the acute treatment of migraine with or without aura in adults ...

Over time, using a nasal aspirator will be second nature, but hopefully something you won’t have to use very often. Look for nasal aspirators with multiple nose tip inserts. Having a correct fit ...

Image: iStock Esketamine nasal spray will soon be subsidised under the Pharmaceutical Benefits Scheme (PBS), making it more affordable for eligible patients starting from May 1. It is the first ...

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment of acute repetitive seizures, also referred to as seizure clusters ...